AI in Drug Discovery Market Size, Share, Trends, Industry Analysis Report: By Offering, By Technology, By Therapeutic Area, By Application, By End User, and By Region

Description

List of Tables

The AI in drug discovery market size is expected to reach USD 16.77 billion by 2034, according to a new study by Polaris Market Research. The report "AI in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Offering (Software, Services), By Technology, By Therapeutic Area, By Application, By End User and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa); Segment Forecast, 2026 - 2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The AI in drug discovery market is experiencing rapid growth, due to rapid adoption of technological advancements, increasing healthcare needs, and evolving pharmaceutical industry dynamics. The escalating demand for more efficient and cost-effective drug development processes is driving demand for the AI in drug discovery market. Traditional drug discovery methods are often time-consuming and expensive, with high failure rates during clinical trials. AI offers a solution by accelerating the identification of potential drug candidates, predicting their efficacy and safety, and optimizing clinical trial designs. This reduces the time and cost associated with drug development, thus contributing to the market growth. Furthermore, the growing prevalence of chronic diseases and the increasing need for personalized medicine is driving demand for AI in drug discovery solutions. With rising aging population and increasing incidence of conditions such as cancer, diabetes, and cardiovascular diseases rises, there is a growing need for new and more effective therapies. AI technologies, including machine learning and deep learning, are particularly well-suited to analyzing large datasets and identifying patterns that may not be apparent through traditional methods. This capability enables the development of targeted therapies tailored to individual patient profiles, improving treatment outcomes and reducing adverse effects.

The adoption of AI in drug discovery is being fueled by substantial investments from both private and public sectors. Governments and healthcare organizations worldwide are recognizing the potential of AI to revolutionize the drug discovery process and are investing in research and development initiatives to foster innovation. Moreover, collaborations between AI technology companies and pharmaceutical giants are also on the rise, with partnerships aimed at integrating AI into various stages of drug development. These collaborations are further supported by advancements in computational power, cloud computing, and big data analytics, which provide the necessary infrastructure for AI applications in drug discovery.

AI in Drug Discovery Market Report Highlights

In 2024, the oncology segment accounted for the largest revenue share in the AI in drug discovery market due to the high demand for innovative cancer treatments and the complexity of cancer research, which benefits significantly from AI-driven solutions.

The pharmaceutical & biotechnology companies segment is anticipated to grow at the fastest CAGR due to their increasing adoption of AI technologies to accelerate drug discovery, reduce development costs, and enhance the precision and efficiency of drug development processes.

In 2024, North America accounted for the largest market share in the AI in drug discovery market due to its advanced healthcare infrastructure, high levels of investment in AI research, and the presence of major pharmaceutical and biotechnology companies leveraging AI for drug development.

The Asia Pacific region is expected to grow at the fastest CAGR in the forecast period due to a large and diverse patient population providing valuable data, and supportive government initiatives fostering innovation in drug discovery.

The global key market players include Atomwise Inc., BenevolentAI, Berg Health (Berg Health acquired by BPGbio Inc.), BioSymetrics, Inc., CYCLICA (Acquired by Recursion Pharmaceuticals), Exscientia, GNS Healthcare (the company Rebranded as Aitia), Google (DeepMind), IBM, Insilico Medicine, insitro.

Polaris Market Research has segmented the AI in drug discovery market report based on offering, technology, therapeutic area, application, end user, and region:

By Offering Outlook (Revenue - USD billion, 2021-2034)

Software

Services

By Technology Outlook (Revenue - USD billion, 2021-2034)

Machine Learning

Deep Learning

Supervised Learning

Reinforcement Learning

Unsupervised Learning

Other Machine Learning Technologies

Other Technologies

By Therapeutic Area Outlook (Revenue - USD billion, 2021-2034)

Oncology

Neurodegenerative Diseases

Cardiovascular Disease

Metabolic Diseases

Infectious Disease

Others

By Application Outlook (Revenue - USD billion, 2021-2034)

Drug optimization & repurposing

Preclinical testing

Others

By End User Outlook (Revenue - USD billion, 2021-2034)

Pharmaceutical & Biotechnology Companies

Contract Research Organizations

Research Centers

Academic & Government Institutes

By Regional Outlook (Revenue - USD billion, 2021-2034)

North America

U.S.

Canada

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Product Code: PM1850

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global AI in Drug Discovery Market Insights

4.1. AI in Drug Discovery Market - Application Snapshot
4.2. AI in Drug Discovery Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Collaboration Between Pharma Companies and AI Providers is Driving Market Growth
  - 4.2.1.2. The Advancements in AI Technology Are Driving the Market Growth.
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Data Privacy and Security Concerns are limiting the growth of AI in Drug Discovery market
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. AI in Drug Discovery Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global AI in Drug Discovery Market, by Offering

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
5.3. Software
- 5.3.1. Global AI in Drug Discovery Market, by Software, by Region, 2021-2034 (USD Billion)
5.4. Services
- 5.4.1. Global AI in Drug Discovery Market, by Services , by Region, 2021-2034 (USD Billion)

6. Global AI in Drug Discovery Market, by Technology

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
6.3. Machine Learning
- 6.3.1. Global AI in Drug Discovery Market, by Machine Learning, by Region, 2021-2034 (USD Billion)
- 6.3.2. Deep Learning
  - 6.3.2.1. Global AI in Drug Discovery Market, by Deep Learning, by Region, 2021-2034 (USD Billion)
- 6.3.3. Supervised Learning
  - 6.3.3.1. Global AI in Drug Discovery Market, by Supervised Learning, by Region, 2021-2034 (USD Billion)
- 6.3.4. Reinforcement Learning
  - 6.3.4.1. Global AI in Drug Discovery Market, by Reinforcement Learning, by Region, 2021-2034 (USD Billion)
- 6.3.5. Unsupervised Learning
  - 6.3.5.1. Global AI in Drug Discovery Market, by Unsupervised Learning, by Region, 2021-2034 (USD Billion)
- 6.3.6. Other Machine Learning Technologies
  - 6.3.6.1. Global AI in Drug Discovery Market, by Other Machine Learning Technologies, by Region, 2021-2034 (USD Billion)
6.4. Other Technologies
- 6.4.1. Global AI in Drug Discovery Market, by Other Technologies, by Region, 2021-2034 (USD Billion)

7. Global AI in Drug Discovery Market, by Therapeutic Area

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
7.3. Oncology
- 7.3.1. Global AI in Drug Discovery Market, by Oncology, by Region, 2021-2034 (USD Billion)
7.4. Neurodegenerative Diseases
- 7.4.1. Global AI in Drug Discovery Market, by Neurodegenerative Diseases, by Region, 2021-2034 (USD Billion)
7.5. Cardiovascular Disease
- 7.5.1. Global AI in Drug Discovery Market, by Cardiovascular Disease, by Region, 2021-2034 (USD Billion)
7.6. Metabolic Diseases
- 7.6.1. Global AI in Drug Discovery Market, by Metabolic Diseases, by Region, 2021-2034 (USD Billion)
7.7. Infectious Disease
- 7.7.1. Global AI in Drug Discovery Market, by Infectious Disease, by Region, 2021-2034 (USD Billion)
7.8. Others
- 7.8.1. Global AI in Drug Discovery Market, by Others, by Region, 2021-2034 (USD Billion)

8. Global AI in Drug Discovery Market, by Application

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
8.3. Drug optimization & repurposing
- 8.3.1. Global AI in Drug Discovery Market, by Drug optimization & repurposing, by Region, 2021-2034 (USD Billion)
8.4. Preclinical testing
- 8.4.1. Global AI in Drug Discovery Market, by Preclinical testing, by Region, 2021-2034 (USD Billion)
8.5. Others
- 8.5.1. Global AI in Drug Discovery Market, by Others, by Region, 2021-2034 (USD Billion)

9. Global AI in Drug Discovery Market, by End User

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
9.3. Pharmaceutical & Biotechnology Companies
- 9.3.1. Global AI in Drug Discovery Market, by Pharmaceutical & Biotechnology Companies, by Region, 2021-2034 (USD Billion)
9.4. Contract Research Organizations
- 9.4.1. Global AI in Drug Discovery Market, by Contract Research Organizations, by Region, 2021-2034 (USD Billion)
9.5. Research Centers
- 9.5.1. Global AI in Drug Discovery Market, by Research Centers, by Region, 2021-2034 (USD Billion)
9.6. Academic & Government Institutes
- 9.6.1. Global AI in Drug Discovery Market, by Academic & Government Institutes, by Region, 2021-2034 (USD Billion)

10. Global AI in Drug Discovery Market, by Geography

10.1. Key Findings
10.2. Introduction
- 10.2.1. AI in Drug Discovery Market Assessment, By Geography, 2021-2034 (USD Billion)
10.3. AI in Drug Discovery Market - North America
- 10.3.1. North America: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
- 10.3.2. North America: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
- 10.3.3. North America: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
- 10.3.4. North America: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
- 10.3.5. North America: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.3.7. AI in Drug Discovery Market - U.S.
  - 10.3.7.1. U.S.: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.3.7.2. U.S.: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.3.7.3. U.S.: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.3.7.4. U.S.: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.3.7.5. U.S.: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.3.8. AI in Drug Discovery Market - Canada
  - 10.3.8.1. Canada: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.3.8.2. Canada: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.3.8.3. Canada: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.3.8.4. Canada: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.3.8.5. Canada: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
10.4. AI in Drug Discovery Market - Europe
- 10.4.1. Europe: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
- 10.4.2. Europe: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
- 10.4.3. Europe: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
- 10.4.4. Europe: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
- 10.4.5. Europe: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.4.6. AI in Drug Discovery Market - UK
  - 10.4.6.1. UK: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.4.6.2. UK: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.4.6.3. UK: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.4.6.4. UK: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.4.6.5. UK: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.4.7. AI in Drug Discovery Market - France
  - 10.4.7.1. France: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.4.7.2. France: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.4.7.3. France: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.4.7.4. France: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.4.7.5. France: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.4.8. AI in Drug Discovery Market - Germany
  - 10.4.8.1. Germany: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.4.8.2. Germany: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.4.8.3. Germany: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.4.8.4. Germany: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.4.8.5. Germany: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.4.9. AI in Drug Discovery Market - Italy
  - 10.4.9.1. Italy: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.4.9.2. Italy: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.4.9.3. Italy: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.4.9.4. Italy: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.4.9.5. Italy: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.4.10. AI in Drug Discovery Market - Spain
  - 10.4.10.1. Spain: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.4.10.2. Spain: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.4.10.3. Spain: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.4.10.4. Spain: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.4.10.5. Spain: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.4.11. AI in Drug Discovery Market - Netherlands
  - 10.4.11.1. Netherlands: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.4.11.2. Netherlands: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.4.11.3. Netherlands: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.4.11.4. Netherlands: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.4.11.5. Netherlands: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.4.12. AI in Drug Discovery Market - Russia
  - 10.4.12.1. Russia: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.4.12.2. Russia: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.4.12.3. Russia: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.4.12.4. Russia: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.4.12.5. Russia: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.4.13. AI in Drug Discovery Market - Rest of Europe
  - 10.4.13.1. Rest of Europe: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.4.13.2. Rest of Europe: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.4.13.3. Rest of Europe: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.4.13.4. Rest of Europe: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.4.13.5. Rest of Europe: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
10.5. AI in Drug Discovery Market - Asia Pacific
- 10.5.1. Asia Pacific: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
- 10.5.2. Asia Pacific: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
- 10.5.3. Asia Pacific: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
- 10.5.4. Asia Pacific: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
- 10.5.5. Asia Pacific: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.5.6. AI in Drug Discovery Market - China
  - 10.5.6.1. China: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.5.6.2. China: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.5.6.3. China: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.5.6.4. China: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.5.6.5. China: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.5.7. AI in Drug Discovery Market - India
  - 10.5.7.1. India: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.5.7.2. India: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.5.7.3. India: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.5.7.4. India: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.5.7.5. India: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.5.8. AI in Drug Discovery Market - Malaysia
  - 10.5.8.1. Malaysia: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.5.8.2. Malaysia: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.5.8.3. Malaysia: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.5.8.4. Malaysia: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.5.8.5. Malaysia: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.5.9. AI in Drug Discovery Market - Japan
  - 10.5.9.1. Japan: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.5.9.2. Japan: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.5.9.3. Japan: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.5.9.4. Japan: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.5.9.5. Japan: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.5.10. AI in Drug Discovery Market - Indonesia
  - 10.5.10.1. Indonesia: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.5.10.2. Indonesia: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.5.10.3. Indonesia: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.5.10.4. Indonesia: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.5.10.5. Indonesia: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.5.11. AI in Drug Discovery Market - South Korea
  - 10.5.11.1. South Korea: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.5.11.2. South Korea: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.5.11.3. South Korea: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.5.11.4. South Korea: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.5.11.5. South Korea: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.5.12. AI in Drug Discovery Market - Australia
  - 10.5.12.1. Australia: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.5.12.2. Australia: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.5.12.3. Australia: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.5.12.4. Australia: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.5.12.5. Australia: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.5.13. AI in Drug Discovery Market - Rest of Asia Pacific
  - 10.5.13.1. Rest of Asia Pacific: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.5.13.2. Rest of Asia Pacific: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.5.13.3. Rest of Asia Pacific: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.5.13.4. Rest of Asia Pacific: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.5.13.5. Rest of Asia Pacific: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
10.6. AI in Drug Discovery Market - Middle East & Africa
- 10.6.1. Middle East & Africa: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
- 10.6.2. Middle East & Africa: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
- 10.6.3. Middle East & Africa: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
- 10.6.4. Middle East & Africa: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
- 10.6.5. Middle East & Africa: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.6.6. AI in Drug Discovery Market - Saudi Arabia
  - 10.6.6.1. Saudi Arabia: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.6.6.2. Saudi Arabia: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.6.6.3. Saudi Arabia: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.6.6.4. Saudi Arabia: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.6.6.5. Saudi Arabia: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.6.7. AI in Drug Discovery Market - UAE
  - 10.6.7.1. UAE: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.6.7.2. UAE: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.6.7.3. UAE: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.6.7.4. UAE: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.6.7.5. UAE: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.6.8. AI in Drug Discovery Market - Israel
  - 10.6.8.1. Israel: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.6.8.2. Israel: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.6.8.3. Israel: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.6.8.4. Israel: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.6.8.5. Israel: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.6.9. AI in Drug Discovery Market - South Africa
  - 10.6.9.1. South Africa: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.6.9.2. South Africa: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.6.9.3. South Africa: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.6.9.4. South Africa: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.6.9.5. South Africa: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.6.10. AI in Drug Discovery Market - Rest of Middle East & Africa
  - 10.6.10.1. Rest of Middle East & Africa: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.6.10.2. Rest of Middle East & Africa: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.6.10.3. Rest of Middle East & Africa: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.6.10.4. Rest of Middle East & Africa: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.6.10.5. Rest of Middle East & Africa: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
10.7. AI in Drug Discovery Market - Latin America
- 10.7.1. Latin America: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
- 10.7.2. Latin America: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
- 10.7.3. Latin America: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
- 10.7.4. Latin America: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
- 10.7.5. Latin America: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.7.6. AI in Drug Discovery Market - Mexico
  - 10.7.6.1. Mexico: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.7.6.2. Mexico: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.7.6.3. Mexico: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.7.6.4. Mexico: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.7.6.5. Mexico: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.7.7. AI in Drug Discovery Market - Brazil
  - 10.7.7.1. Brazil: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.7.7.2. Brazil: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.7.7.3. Brazil: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.7.7.4. Brazil: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.7.7.5. Brazil: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.7.8. AI in Drug Discovery Market - Argentina
  - 10.7.8.1. Argentina: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.7.8.2. Argentina: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.7.8.3. Argentina: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.7.8.4. Argentina: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.7.8.5. Argentina: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)
- 10.7.9. AI in Drug Discovery Market - Rest of Latin America
  - 10.7.9.1. Rest of Latin America: AI in Drug Discovery Market, by Offering, 2021-2034 (USD Billion)
  - 10.7.9.2. Rest of Latin America: AI in Drug Discovery Market, by Technology, 2021-2034 (USD Billion)
  - 10.7.9.3. Rest of Latin America: AI in Drug Discovery Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.7.9.4. Rest of Latin America: AI in Drug Discovery Market, by Application, 2021-2034 (USD Billion)
  - 10.7.9.5. Rest of Latin America: AI in Drug Discovery Market, by End User, 2021-2034 (USD Billion)

11. Competitive Landscape

11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

12.1. Atomwise Inc.
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
12.2. BenevolentAI
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
12.3. Berg Health
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
12.4. BioSymetrics, Inc.
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
12.5. CYCLICA
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
12.6. Exscientia
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
12.7. GNS Healthcare
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
12.8. Google
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
12.9. IBM
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
12.10. Insilico Medicine
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
12.11. insitro
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development